Navigating Particulate Matter Analysis in Biologic Drug Products: A Critical Evaluation of Flow Imaging and Light Obscuration for Product Quality Assessment

Particulate matter control is a cornerstone of biologic drug product quality, yet the analytical methods used to characterize it are not without limitations. Light Obscuration (LO), the compendial standard under USP , has been widely adopted across the industry; however, accumulating evidence suggests it may systematically underestimate proteinaceous particulate burden in complex biologics including monoclonal.

Navigating Particulate Matter Analysis in Biologic Drug Products: A Critical Evaluation of Flow Imaging and Light Obscuration for Product Quality Assessment is an official webinar listing associated with BioPharma Webinars. Visit the company-owned event page for the organizer's latest agenda, access details, availability, and registration or viewing instructions.

UPCOMING provides this independent listing to help professionals discover the session and routes outbound visitors to the official company source with referral attribution.